Following treatment with GHK-Cu, this index was significantly reduced (Figure 2C)
[4] [6] Medication review: A thorough review of concomitant medicines that may independently raise heart rate is advisable, including sympathomimetics, SNRIs, tricyclic antidepressants, and beta-2 agonists Lifestyle measures: Reducing caffeine intake, managing stress, and ensuring adequate sleep can all contribute to heart rate regulation Cardiac monitoring: In patients with pre-existing cardiac conditions, an electrocardiogram (ECG) or ambulatory heart rate monitoring may be warranted Specialist referral: If tachycardia persists or is associated with arrhythmia, referral to a cardiologist should be considered In some cases, if the heart rate elevation is persistent and symptomatic despite dose adjustment, discontinuation of retatrutide may be necessary
PMID: 31743774
10.1111/febs.70139 55 HauffeR.RathM.ChopraS.MllerK.KleinriddersA
[4] Andr J Scheen
For example, given the inconsistency in the prevalence estimates of mitochondrial disease and dysfunction across studies (ranging from about 580%), the notion that mitochondrial abnormalities are even associated with ASD is somewhat controversial